title: Mutations in novel peroxin gene PEX26 that cause peroxisome-biogenesis disorders of complementation group 8 provide a genotype-phenotype correlation.
abstract: The human disorders of peroxisome biogenesis (PBDs) are subdivided into 12 complementation groups (CGs). CG8 is one of the more common of these and is associated with varying phenotypes, ranging from the most severe, Zellweger syndrome (ZS), to the milder neonatal adrenoleukodystrophy (NALD) and infantile Refsum disease (IRD). PEX26, encoding the 305-amino-acid membrane peroxin, has been shown to be deficient in CG8. We studied the PEX26 genotype in fibroblasts of eight CG8 patients--four with the ZS phenotype, two with NALD, and two with IRD. Catalase was mostly cytosolic in all these cell lines, but import of the proteins that contained PTS1, the SKL peroxisome targeting sequence, was normal. Expression of PEX26 reestablished peroxisomes in all eight cell lines, confirming that PEX26 defects are pathogenic in CG8 patients. When cells were cultured at 30 degrees C, catalase import was restored in the cell lines from patients with the NALD and IRD phenotypes, but to a much lesser extent in those with the ZS phenotype, indicating that temperature sensitivity varied inversely with the severity of the clinical phenotype. Several types of mutations were identified, including homozygous G89R mutations in two patients with ZS. Expression of these PEX26 mutations in pex26 Chinese hamster ovary cells resulted in cell phenotypes similar to those in the human cell lines. These findings confirm that the degree of temperature sensitivity in pex26 cell lines is predictive of the clinical phenotype in patients with PEX26 deficiency.
authors.affiliation: Department of Biology, Faculty of Sciences, Kyushu University Graduate School, Fukuoka, Japan.
authors.forename: Naomi
authors.initials: N
authors.lastname: Matsumoto
authors.forename: Shigehiko
authors.initials: S
authors.lastname: Tamura
authors.forename: Satomi
authors.initials: S
authors.lastname: Furuki
authors.forename: Non
authors.initials: N
authors.lastname: Miyata
authors.forename: Ann
authors.initials: A
authors.lastname: Moser
authors.forename: Nobuyuki
authors.initials: N
authors.lastname: Shimozawa
authors.forename: Hugo W
authors.initials: HW
authors.lastname: Moser
authors.forename: Yasuyuki
authors.initials: Y
authors.lastname: Suzuki
authors.forename: Naomi
authors.initials: N
authors.lastname: Kondo
authors.forename: Yukio
authors.initials: Y
authors.lastname: Fujiki
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D016466:CHO Cells; D002374:Catalase / Q000378:metabolism; D002460:Cell Line; D006224:Cricetinae; D004247:DNA / Q000235:genetics; D004252:DNA Mutational Analysis; D005260:Female; D015870:Gene Expression; D005816:Genetic Complementation Test; D005838:Genotype; D006801:Humans; D008565:Membrane Proteins / Q000172:deficiency / Q000235:genetics*; D051379:Mice; D008969:Molecular Sequence Data; D009154:Mutation; D018901:Peroxisomal Disorders / Q000145:classification / Q000235:genetics* / Q000378:metabolism; D000074435:Peroxisome-Targeting Signal 1 Receptor; D010641:Phenotype; D011247:Pregnancy; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D018160:Receptors, Cytoplasmic and Nuclear / Q000378:metabolism; D017386:Sequence Homology, Amino Acid; D013696:Temperature; D014018:Tissue Distribution; D014162:Transfection; D015211:Zellweger Syndrome / Q000235:genetics / Q000378:metabolism
chemical_list: D008565:Membrane Proteins; C474612:PEX26 protein, human; D000074435:Peroxisome-Targeting Signal 1 Receptor; D012333:RNA, Messenger; D018160:Receptors, Cytoplasmic and Nuclear; D004247:DNA; D002374:Catalase